Reliance Chemotex Q1 Results: Net Profit Rises 36% YoY to ₹1.37 crore

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

Reliance Chemotex Industries posted strong Q1FY26 results with net profit rising 36% YoY to ₹1.37 crore. Operating income grew 7.5% to ₹997.15 lakh. EPS increased to ₹1.81 from ₹1.41. The company also extended its physical share demat window until February 2027.

powered bylight_fuzz_icon
48148768

*this image is generated using AI for illustrative purposes only.

Reliance Chemotex Industries Limited reported a 36% year-on-year increase in net profit after tax for the quarter ended June 30, 2026. The company’s bottom line rose to ₹1.37 crore from ₹1.06 crore in the same period of FY25, supported by higher operating income.

Operating income grew 7.5% to ₹997.15 lakh, up from ₹927.54 lakh in Q1FY25. Earnings per share (EPS) increased to ₹1.81 from ₹1.41 in the prior year quarter. The results were reviewed by the Audit Committee and approved by the Board of Directors on August 11, 2026.

Financial Highlights

Metric: Q1FY26: Q1FY25: Change:
Operating Income: ₹997.15 lakh ₹927.54 lakh +7.5%
Net Profit (Pre-Tax): ₹1.30 lakh ₹95.51 lakh +36.1%
Net Profit (Post-Tax): ₹1.37 crore ₹1.06 crore +28.5%
EPS (Basic): ₹1.81 ₹1.41 +28.4%

Comprehensive income stood at ₹1.51 crore, compared to ₹1.15 crore in the previous year. The company operates in a single reportable segment: Yarns.

What the Numbers Show

The divergence between revenue growth and profit expansion indicates improved operational efficiency or cost management during the period. While operating income grew by 7.5%, pre-tax profits surged by 36%, suggesting that cost savings or favorable mix shifts contributed disproportionately to the bottom line relative to top-line growth.

Shareholder Update

Reliance Chemotex also announced an extension of the special window for transfer and dematerialisation of physical securities. Eligible shareholders can re-lodge transfer requests for deeds lodged prior to April 1, 2019, until February 4, 2027. Shares will be issued only in dematerialised form.

Historical Stock Returns for Reliance Chemotex

1 Day5 Days1 Month6 Months1 Year5 Years
-0.81%-0.33%-11.01%-7.87%-32.89%0.0%

Will the cost efficiencies driving the 36% profit surge despite only 7.5% revenue growth be sustainable in Q2FY26, or were they one-off adjustments?

How might the extension of the dematerialisation window until February 2027 impact the company's share liquidity and shareholder base composition?

Given the reliance on a single reportable segment (Yarns), what strategic steps is Reliance Chemotex taking to mitigate sector-specific volatility?

Reliance Chemotex re-appoints Sanjiv Shroff as MD for 3 years

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

Reliance Chemotex Industries Limited Board re-appoints Sanjiv Shroff as Managing Director for three years, effective September 1, 2026. The move ensures leadership stability for the Udaipur-based chemical firm, with the appointment subject to shareholder approval. Shroff, who has led the company since 1988, continues to guide operations alongside his sons, Rahul and Ameya Shroff, who serve as Executive Directors.

powered bylight_fuzz_icon
47982133

*this image is generated using AI for illustrative purposes only.

Reliance Chemotex Industries Limited has approved the re-appointment of Sanjiv Shroff as its Managing Director for a further period of three years, signaling continuity in its leadership structure. The Board of Directors made the decision during a meeting held on August 11, 2026, via video conferencing. The new term commences on September 1, 2026, and concludes on August 31, 2029. This appointment requires final approval from the shareholders of the company.

The resolution was passed pursuant to Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board meeting commenced at 11:45 A.M. and concluded at 12:30 P.M. Chandrasekaran Rajagopalan, CFO cum Company Secretary and Compliance Officer, signed the disclosure submitted to the Bombay Stock Exchange and the National Stock Exchange of India.

Leadership Continuity

Sanjiv Shroff (DIN: 00296008) has been a central figure in the company’s governance since joining Reliance Chemotex Industries Limited in 1983. A graduate with Chemistry Honors from Calcutta University, he assumed the role of Managing Director in 1988. His tenure spans over four decades, during which he has overseen significant operational growth and industry expansion for the Udaipur-based chemical manufacturer.

The filing confirms that Mr. Sanjiv Shroff is not debarred from holding the office of Director by virtue of any order passed by SEBI or any other regulatory authority. This compliance statement aligns with requirements set forth by the National Stock Exchange of India Ltd under reference number NSEICML/2018/24, dated June 20, 2018.

Family Governance Structure

The re-appointment reinforces the family-led management structure at Reliance Chemotex Industries Limited. The disclosure highlights key familial relationships within the boardroom:

Relationship Name Designation
Son Rahul Shroff Whole-time Director, designated as Executive Director
Son Ameya Shroff Whole-time Director, designated as Executive Director

Both Rahul Shroff and Ameya Shroff serve as Whole-time Directors with the designation of Executive Director. Their presence on the board ensures that strategic decision-making remains consolidated within the founding family, a common trait in many Indian mid-cap manufacturing firms.

Next Steps

While the Board has formally approved the re-appointment, the process is not yet complete. Shareholder approval is mandatory for the appointment to take effect on September 1, 2026. The company will likely seek this consent through an Ordinary Resolution at an upcoming General Meeting or via Postal Ballot, depending on the procedural requirements at that time. Until then, the existing management structure remains in place without disruption.

Historical Stock Returns for Reliance Chemotex

1 Day5 Days1 Month6 Months1 Year5 Years
-0.81%-0.33%-11.01%-7.87%-32.89%0.0%

How might the re-appointment of Sanjiv Shroff influence Reliance Chemotex's strategic roadmap for the 2026-2029 period regarding operational expansion or digital transformation?

What is the expected timeline and format for the shareholder vote, and are there any indications of dissent that could delay the September 1, 2026 commencement date?

How does the continued consolidation of leadership within the Shroff family impact the company's governance ratings and appeal to institutional investors seeking diverse board structures?

More News on Reliance Chemotex

1 Year Returns:-32.89%